Researcher Profile Statistics: Valés-Gómez, Mar

From: ever To: now Change date range

Email Alert

RSS Feed

Mapa Geográfico

Region	#
NA - North America	1237
EU - Europa	869
AS - Asia, other	637
SA - South America	98
OC - Oceania	11
AF - Africa	2
Desconocidos	4416
Total	7270

Guardar como PNG Guardar como JPEG

Country	#
US - United States of America	1172
CN - China	604
ES - Spain	533
IE - Ireland	105
DE - Germany	68
FR - France	53
MX - Mexico	37
TR - Turkey	35
CL - Chile	23
EC - Ecuador	23
other - Other Country	4617
Total	7270

Guardar como PNG Guardar como JPEG

City	#
Ashburn	583
Hangzhou	378
Madrid	96
Dublin	95
Boydton	78
Beijing	59
Boardman	51
Girne	35
Phoenix	30
Seville	21
other	5660
Total	7086

Guardar como PNG Guardar como JPEG

Most viewed items	#
ID: 408918 - Test de anticuerpos de Covid-19 del CSIC, con una fiabilidad de casi el 100%	763
ID: 398467 - SARS-Cov-2 cysteine-like protease (Mpro) is immunogenic and can be detected in serum and saliva of COVID-19-seropositive individuals	459
ID: 48774 - The human NKG2D ligand ULBP2 can be expressed at the cell surface with or without a GPI anchor and both forms can activate NK cells	413
ID: 344047 - Immunoassays for scarce tumour-antigens in exosomes: detection of the human NKG2D-Ligand, MICA, in tetraspanin-containing nanovesicles from melanoma	367
ID: 48772 - Palmitoylation of MICA, a ligand for NKG2D, mediates its recruitment to membrane microdomains and promotes its shedding	365
ID: 340214 - Analysis of the recovery of CD247 expression in a PID patient: Insights into the spontaneous repair of defective genes	331
ID: 340228 - Natural killer cell hyporesponsiveness and impaired development in a CD247-deficient patient	321
ID: 332496 - Human NKG2D-ligands: cell biology strategies to ensure immune recognition	310
ID: 423485 - Plataforma Salud Global del CSIC. Un año de investigación de la covid-19	309
ID: 340307 - A short half-life of ULBP1 at the cell surface due to internalization and proteosomal degradation	292
ID: 332209 - NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation	262
ID: 367049 - BCG Therapy of bladder cancer stimulates a prolonged release of the chemoattractant CXCL10 (IP10) in patient urine	260
ID: 461458 - II Encuentro del CSIC ++ 2022	227
ID: 332230 - The Impact of Glycosyl-Phosphatidyl-Inositol Anchored MICA Alleles on Novel NKG2D-Based Therapies	218
ID: 403975 - SARS-CoV-2 Cysteine-like Protease Antibodies Can Be Detected in Serum and Saliva of COVID-19–Seropositive Individuals	199
ID: 419103 - Bead-assisted SARS-CoV-2 multi-antigen serological test allows effective identification of patients	196
ID: 383673 - Exosome beads array for multiplexed phenotyping in cancer	177
ID: 395328 - High sensitivity detection of extracellular vesicles immune-captured from urine by conventional flow cytometry	172
ID: 395560 - Characterization of a Human Anti-Tumoral NK Cell Population Expanded After BCG Treatment of Leukocytes	158
ID: 395334 - NKG2H-expressing T cells negatively regulate immune responses	155
ID: 411299 - Bladder cancer immunological background and biomarkers Bases inmunológicas del cáncer vesical y biomarcadores	154
ID: 405860 - Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID‐19 patients	152
ID: 395563 - Impaired NK cell recognition of vemurafenib-treated melanoma cells is overcome by simultaneous application of histone deacetylase inhibitors	151
ID: 395331 - Tetraspanin-decorated extracellular vesicle-mimetics as a novel adaptable reference material	143
ID: 395939 - Bacillus Calmette Guérin in bladder cancer: Is more immune stimulation better?	123
ID: 410410 - Identification of the first cases of complete CD16A deficiency: Association with persistent EBV infection	112
ID: 431034 - Single-reaction multi-antigen serological test for comprehensive evaluation of SARS-CoV-2 patients by flow cytometry	93
ID: 453077 - CD4+ T Cell Immune Specificity Changes After Vaccination in Healthy And COVID-19 Convalescent Subjects	76
ID: 453349 - Cross-reactive cellular, but not humoral, immunity is detected between OC43 and SARS-CoV-2 NPs in people not infected with SARS-CoV-2: Possible role of cTFH cells	54
ID: 456889 - Assay for the detection of the cys-like protease (MPRO) of SARS-CoV-2	49
ID: 479095 - Method for the detection and/or quantification of extracellular vesicles in fluid biological samples	41
ID: 479097 - Method for the detection and/or quantification of extracellular vesicles in fluid biological samples	40
ID: 550519 - SARS-CoV-2 membrane protein-specific antibodies from critically ill SARS-CoV-2–infected individuals interact with Fc receptor–expressing cells but do not neutralize the virus	24
ID: 550610 - Immune evasion by proteolytic shedding of natural killer group 2, member D ligands in Helicobacter pylori infection	20
ID: 550529 - Elevated levels of cell-free NKG2D-ligands modulate NKG2D surface expression and compromise NK cell function in severe COVID-19 disease	18
ID: 550601 - Natural killer (NK) cell-derived extracellular-vesicle shuttled microRNAs control T cell responses	18
ID: 545721 - A simple immunoassay for extracellular vesicle liquid biopsy in microliters of non-processed plasma	17
ID: 545855 - ALK-Fusion Transcripts Can Be Detected in Extracellular Vesicles (EVs) from Nonsmall Cell Lung Cancer Cell Lines and Patient Plasma: Toward EV-Based Noninvasive Testing	16
ID: 545724 - MAPK inhibitors dynamically affect melanoma release of immune NKG2D-ligands, as soluble protein and extracellular vesicle-associated	15
Total	7270

Guardar como PNG Guardar como JPEG

Most type viewed	#
ID: other -	0
ID: journal -	5410
ID: conference -	0
ID: patent -	130
ID: book -	0
ID: dataset -	0
ID: selected -	0
Total	5540

Guardar como PNG Guardar como JPEG

	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Tot
2019	0	0	0	0	116	99	78	85	66	76	118	100	738
2020	82	70	122	88	74	238	127	216	151	97	127	188	1580
2021	158	259	244	295	195	210	300	158	204	333	93	78	2527
2022	65	63	51	89	88	68	36	48	33	100	45	84	770
2023	63	33	45	29	63	23	17	29	107	104	98	111	722
2024	110	161	127	73	3	0	0	0	0	0	0	0	474
Ever													7270